We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

38 hedge funds and large institutions have $76.6M invested in Fibrocell Science Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less funds holding

Funds holding: 4438 (-6)

28% less capital invested

Capital invested by funds: $107M → $76.6M (-$30.3M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
8
Reduced
12
Closed
10
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$60K

FCSC Hedge Fund Activity: Q3 2014 in Review

38 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2014, worth a combined $76.6M — down 28% from $107M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FCSC and 4 opened new positions — a net loss of 6 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $647K. The largest seller was Belmont Global Advisors, cutting an estimated $780K.

  • 38 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2014, down from 44 in Q2 2014.
  • Funds reported $76.6M of Fibrocell Science Inc. stock for Q3 2014, down 28% quarter-over-quarter.
  • 4 funds opened new Fibrocell Science Inc. positions in Q3 2014 and 10 closed out, a net change of -6 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2014 was Cambridge Investment Research Advisors, an estimated $647K added.
  • The largest Fibrocell Science Inc. seller in Q3 2014 was Belmont Global Advisors, an estimated $780K sold.

Based on aggregated 13F filings for Q3 2014.